Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
NPHP1 encodes nephrocystin-1, a ciliary transition zone protein whose autosomal recessive loss leads to juvenile nephronophthisis type 1, characterised by corticomedullary cysts, tubular basement membrane fibrosis and progression to end-stage renal disease in childhood. NPHP1 is the most frequent genetic cause of this renal ciliopathy, accounting for 6–10% of paediatric ESRD.
Genetic analyses in multiple cohorts have identified homozygous deletions of NPHP1 in 74 families (115 affected individuals) and compound heterozygous deletions with point mutations in 5 additional families ([PMID:8995741]). Linkage and haplotype studies demonstrated segregation in 10 of 16 families, and 61 multiplex kindreds showed consistent co-segregation of NPHP1 loss with disease ([PMID:8995741], [PMID:11168925]).
Variant spectrum comprises a recurrent ~290 kb whole-gene deletion, splice alterations and missense substitution c.859G>A (p.Gly287Arg) ([PMID:11168925]), as well as rare missense c.1589G>A (p.Arg530Gln) in compound heterozygotes ([PMID:27004562]). No clear founder effect beyond the common deletion has been reported.
Patient-derived and gene-edited hiPSC kidney organoids lacking NPHP1 show defective primary cilia and frequent cyst formation in suspension culture, both rescued by NPHP1 overexpression ([PMID:38989059]). A CRISPR/Cas9 Nphp1 exon 2–20 knockout mouse replicates human renal cystic and extrarenal phenotypes; AAV-mediated Nphp1 re-expression partially rescues both renal and retinal pathology ([PMID:34415307]).
Some juvenile nephronophthisis families lack NPHP1 linkage, reflecting genetic heterogeneity with NPHP3 and other loci ([PMID:7806215], [PMID:11274269]); these findings do not dispute the NPHP1 association but underscore locus diversity.
Collectively, robust segregation in >74 families, concordant functional modelling in organoids and mouse, and a clear loss-of-function mechanism support a definitive gene–disease relationship. Key take-home: NPHP1 molecular testing is essential for early diagnosis, prognosis and genetic counselling in juvenile nephronophthisis.
Gene–Disease AssociationDefinitiveHomozygous deletions in >115 patients across 74 families, multi-family segregation, concordant functional models Genetic EvidenceStrong115 patients with homozygous deletions and 5 with compound heterozygous variants, segregation in 61 multiplex families Functional EvidenceStronghiPSC organoids and CRISPR mouse knockout replicate cystic phenotype with rescue by NPHP1 re-expression |